Sector: MedicalPharmacopeia Drug Discovery, Inc. (NASDAQ: PCOP)
Ranking History
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 260 |
Technical : | 25 |
Performance : | 39 |
Overall: | 76 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 262 |
Technical : | 29 |
Performance : | 28 |
Overall: | 70 |
Number of Stocks: | 306 |
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 259 |
Technical : | 65 |
Performance : | 41 |
Overall: | 94 |
Number of Stocks: | 306 |
Headlines
- Pharmacopeia Continues Decline
Oct 03, 2008 01:08 PM | PCOP
- CombinatoRx to Present at the Canaccord Adams Diabetes & Obesity Conference and Pharmacopeia Advances Strategic Plan to Focus Resources on Development and Later-Stage Discovery Programs
May 30, 2008 11:29 AM | CRXX, GENR, PCOP
- Chasing Performance
May 16, 2008 12:00 PM | AAP, ACGY, AKNS, ALD, ASTI, BMC
- Is Bad News Already Priced In?
Apr 11, 2008 10:16 AM | ACPW, AKNS, AMGN, ARRS, BLK, CEGE
- XOMA Announces Conference Call to Provide Overview of Business Strategy and Pharmacopeia To Present at BMO Capital Markets' Seventh Annual Focus on Healthcare Conference
Nov 27, 2007 09:28 AM | ITMN, PCOP, XOMA
- NASDAQ Technical Picture - Choppy Snooze Fest Ahead of Jobs Data
Aug 02, 2007 11:27 PM | ABCO, ABVA, ADBL, ALKS, ATVI, AW
- Movers: GE, Nike, Discover Financial, Capital One, Goodyear
Sep 26, 2008 10:58 AM | ALOG, CHRK, CHTT, COF, CRAI, CSUN
- Pharmacopeia to Request a Hearing With NASDAQ Following Receipt of Notice of Non-Compliance
Nov 07, 2008 04:02 PM | PCOP
- Pharmacopeia Announces Third Quarter 2008 Financial Results
Nov 06, 2008 04:01 PM | PCOP
- Ligand and Pharmacopeia to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
Nov 04, 2008 07:30 AM | LGND, PCOP
- Ligand and Pharmacopeia to Present At the Oppenheimer 19th Annual Healthcare Conference
Oct 28, 2008 04:01 PM | LGND, PCOP
- Pharmacopeia Receives Notification From NASDAQ
Oct 03, 2008 07:30 AM | PCOP
- Ligand to Acquire Pharmacopeia for Stock and Contingent Value Rights - PrimeZone
Sep 24, 2008 06:01 PM | LGND, PCOP
- Ligand to Acquire Pharmacopeia for Stock and Contingent Value Rights - Business Wire
Sep 24, 2008 05:11 PM | LGND, PCOP
- Pharmacopeia and GlaxoSmithKline Collaboration Identifies Sixth Lead Compound
Sep 16, 2008 07:32 AM | PCOP
- Pharmacopeia Announces Further Reductions to Workforce
Aug 05, 2008 07:31 AM | PCOP
- Pharmacopeia Announces Second Quarter 2008 Financial Results
Jul 31, 2008 04:01 PM | PCOP
- Form 4 PHARMACOPEIA INC For: Dec 23 Filed by: WEBB MARIA L (10K)
Dec 24, 2008 11:10 AM
- Form 4 Soeters Martinus Hermanu For: Dec 23 (10K)
Dec 24, 2008 11:10 AM
- Form 4 PHARMACOPEIA INC For: Dec 23 Filed by: MOLLICA JOSEPH A (10K)
Dec 24, 2008 11:10 AM
- Form 4 Costalas Stephen C For: Dec 23 (10K)
Dec 24, 2008 11:10 AM
- Form 4 PHARMACOPEIA INC For: Dec 23 Filed by: POSNER BRIAN M (10K)
Dec 24, 2008 11:10 AM
- Form 4 Belder Rene For: Dec 23 (10K)
Dec 24, 2008 11:10 AM
- Form 4 BARTLETT PAUL A For: Dec 23 (10K)
Dec 24, 2008 11:10 AM
- Form 4 PHARMACOPEIA INC For: Oct 31 Filed by: WEBB MARIA L (10K)
Nov 03, 2008 04:41 PM
- Form 4 PHARMACOPEIA INC For: Oct 31 Filed by: MOLLICA JOSEPH A (10K)
Nov 03, 2008 04:41 PM
- Form 3 PHARMACOPEIA INC For: Oct 13 Filed by: El Coronado Holdings, LLC (10K)
Oct 23, 2008 04:58 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
PCOP
|
Compare to S&P
|
| YTD |
-64.57 %
|
-40.71 %
|
| 4 Weeks |
87.78 %
|
83.51 %
|
| 12 Weeks |
13.42 %
|
43.97 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 40.82 %
|
|
EPS Growth in Last Year: 27.50 %
|
|
Sales Growth in Last Quarter: 0.68 %
|
|
Sales Growth in Last Quarter: 16.37 %
|
|
